[go: up one dir, main page]

MX9706143A - Formulacion transdermica. - Google Patents

Formulacion transdermica.

Info

Publication number
MX9706143A
MX9706143A MX9706143A MX9706143A MX9706143A MX 9706143 A MX9706143 A MX 9706143A MX 9706143 A MX9706143 A MX 9706143A MX 9706143 A MX9706143 A MX 9706143A MX 9706143 A MX9706143 A MX 9706143A
Authority
MX
Mexico
Prior art keywords
transdermal formulation
butylthio
thiadiazol
azabicyclo
octane
Prior art date
Application number
MX9706143A
Other languages
English (en)
Other versions
MXPA97006143A (es
Inventor
Franklin Porter Bymaster
Harlan Edgar Shannon
Lisa Ann Shipley
Kirti Himatlal Valia
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of MX9706143A publication Critical patent/MX9706143A/es
Publication of MXPA97006143A publication Critical patent/MXPA97006143A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F13/02—Adhesive bandages or dressings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invencion proporciona un método para la preparacion de una condicion asociada con la modulacion de los receptores muscarínicos, utilizando una formulacion transdérmica de 3-[4-(butiltio)-1,2,5-tiadiazol-3-il]-1-azabiciclo [2.2.2]octano. La invencion proporciona las formulaciones de parches transdérmicos deseadas de 3-[4-(butiltio)-1,2,5-tiadiazol-3-il]-1-azabiciclo [2.2.2]octano.
MXPA/A/1997/006143A 1995-02-17 1997-08-12 Formulacion transdermica MXPA97006143A (es)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US39044595A 1995-02-17 1995-02-17
US390445 1995-02-17
US48101695A 1995-06-07 1995-06-07
US481016 1995-06-07
PCT/US1996/001371 WO1996025154A1 (en) 1995-02-17 1996-02-01 Transdermal formulation

Publications (2)

Publication Number Publication Date
MX9706143A true MX9706143A (es) 1997-11-29
MXPA97006143A MXPA97006143A (es) 1998-07-03

Family

ID=

Also Published As

Publication number Publication date
CO4700408A1 (es) 1998-12-29
ES2159683T3 (es) 2001-10-16
CN1181007A (zh) 1998-05-06
US5858393A (en) 1999-01-12
WO1996025154A1 (en) 1996-08-22
FI973362L (fi) 1997-08-15
DE69614419T2 (de) 2002-05-23
CA2212874A1 (en) 1996-08-22
CZ255097A3 (en) 1997-12-17
HUP9802070A3 (en) 2000-09-28
IL116997A0 (en) 1996-06-18
YU6196A (sh) 1998-09-18
NZ302147A (en) 1998-10-28
TR199700799T1 (xx) 1998-02-21
NO973715D0 (no) 1997-08-12
BR9607722A (pt) 1998-07-14
PE17897A1 (es) 1997-06-12
KR19980702239A (ko) 1998-07-15
EP0727208A1 (en) 1996-08-21
JPH11505513A (ja) 1999-05-21
HUP9802070A2 (hu) 1999-02-01
AR002027A1 (es) 1998-01-07
EP0727208B1 (en) 2001-08-16
AU4774296A (en) 1996-09-04
DE69614419D1 (de) 2001-09-20
AU700023B2 (en) 1998-12-17
FI973362A0 (fi) 1997-08-15
NO973715L (no) 1997-08-12
FI973362A7 (fi) 1997-08-15

Similar Documents

Publication Publication Date Title
IT1226146B (it) Composizione insetticida organofosforica microincapsulata per uso agricolo.
BG102474A (en) (-)-cis-6(s)-phenyl-5(r)-[4-(2-pyrrolidine-1-yletoxi)phenyl)-5,6,7 ,8-tetrahydronaphthalen-2-ol-d-tartarate
ES548168A0 (es) Procedimiento para preparar composiciones de uso cosmetico o farmaceutico a base de unas esferulas lipidicas que contienen un polimero de poliamida.
DK0893064T3 (da) Lipidsammensætning til præparater til spædbørn samt fremstillingsfremgangsmåde for denne
DK0378404T3 (da) Dispenserende indretninger drevet af hydrogel
ES2190479T3 (es) Moduladores de rxr selectivos a dimeros y metodos para su uso.
PT1002243E (pt) Metodo para a preparacao de materiais para dispositivos oftalmicos hidrofilicos dobraveis
ES2158327T3 (es) Derivados de benzo(g)quinolina.
AU5848480A (en) 2-(pyrimidinyl-amino)-1,3-diaza-2-cycloalkene derivatives
AU3321389A (en) Cultivator tool for planting seedlings
FI981956A0 (fi) 2-(4-hydroksipiperidino)-1-alkanolijohdannaisia verettömyyden vastaisia aineina
TR199700799T1 (xx) Transdermal form�lasyon.
NO963749L (no) Transdermalt system i form av et plaster med et tamoxifen-derivat
DK50885A (da) 2-cyan-benzimidazolderivater, fremgangsmaade til fremstilling deraf samt anvendelse af saadanne forbindelser som fungicider
ATE49882T1 (de) Sebosuppressive kosmetische mittel, enthaltend benzylalkohol-derivate.
DK0874625T3 (da) Indanderivater til antipsykotiske præparater
DK0692484T3 (da) Benzothiadiazinderivat, fremgangsmåde til fremstilling deraf samt farmaceutiske sammensætninger indeholdende derivatet
NO913254D0 (no) Fremgangsmaate for fremstilling av et soetet tyggegummiblanding.
DK436784A (da) Beta-butyrolacton-derivater, fremgangsmaade til deres fremstilling samt immunomodulerende midler indeholdende disse derivater som aktive bestanddele
AU4009497A (en) Substituted pyrazolyl-pyrazole derivatives, process for their preparation nd their use as agents with a herbicidal effect
YU10599A (sh) Amorfni benzotiofeni, postupak dobijanja istih i njihova farmaceutska formulacija
ES2179529T3 (es) Compuestos biaromaticos unidos por un radical heteroetinileno, y composiciones farmaceuticas y cosmeticas que los contienen.
AU2143095A (en) Levelling blade with vibrating shoes for making road embankments
EP0791572A4 (en) SUBSTITUTED BICYCLOHEPTANDIONE AND HERBICIDES
DK166352C (da) Azolylmethylcyclopentanderivat, fremgangsmaade til fremstilling heraf samt landbrugsmaessigt/havebrugsmaessigt fungicid indeholdende derivatet som aktiv bestanddel